Meet Novalix at the 15th Annual World ADC London 2025!
World ADC London is a leading European conference on antibody-drug conjugates (ADC) dedicated to the biopharma sector. This annual focus is: “Maximize the therapeutic index and accelerate your ADC journey from concept to approved therapy”.
Over 110 global expert speakers are expected at World ADC.
The structural heterogeneity and complexity of ADCs demands advanced analytical and bioanalytical characterization to ensure quality and efficacy.
At Novalix, we apply our specialized expertise and resources to support ADCs discovery phase. Our experienced teams ensure efficient project execution, delivering high-quality results with a seamless, collaborative approach.
With deep expertise in biophysical techniques, biochemistry, and bioassays, we provide comprehensive solutions to assess key ADCs attributes, including drug distribution, naked antibody content, and drug-to-antibody ratio (DAR)—empowering ADC development with precision and reliability.
Meet our BD team to check how we can support your projects!
Conference location:
Novotel London West, UK
Event
Visit websiteDate
From
Mar 03, 2025
to
Mar 06, 2025
Location
London, UK
Attendees
Anne Pecquery
Director Business Development Drug Discovery and Pharmacology